Allergen Pro-Toothpaste Formulation for Stable Oral Mucosal Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing toothpaste formulations for oral mucosal immunotherapy (OMIT) face challenges in achieving consumer-acceptable stability, consistency, and texture while effectively delivering allergens, leading to low compliance and unsatisfactory treatment outcomes.
Innovation Solution
Formulating a pro-toothpaste composition with reduced vehicle volume and increased viscosity modifiers, such as sugar alcohols and silica-based thickeners, to create a stable and consumer-friendly toothpaste that can be combined with allergen solutions, ensuring homogeneous mixing and daily use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional toothpaste formulations are used for oral mucosal immunotherapy, then allergen delivery is achieved, but stability, consistency, and texture are compromised leading to low consumer acceptance
Solution Approach 1:
The patent modifies the physical and chemical parameters of the toothpaste formulation by adjusting the ratio of hydrophilic to hydrophobic components, optimizing viscosity, and controlling particle size distribution of the allergen. These parameter changes enable the formulation to maintain both allergen delivery efficacy and consumer-acceptable stability and consistency.
Solution Approach 2:
The patent employs composite material strategies by combining allergen particles with toothpaste base materials that have complementary properties. The formulation integrates hydrophilic and hydrophobic components, along with various excipients, to create a composite system that simultaneously achieves allergen stability, consistent texture, and consumer acceptance.
2Reliability
If allergen concentration is increased to improve treatment efficacy, then immunotherapy effectiveness improves, but formulation stability and consumer acceptance deteriorate
Solution Approach 1:
The patent applies local quality by creating distinct micro-environments within the toothpaste formulation. Allergen particles are distributed throughout the matrix with localized concentrations optimized for immunotherapy effectiveness, while the surrounding toothpaste base maintains properties acceptable to consumers. This spatial differentiation allows high allergen concentration without compromising overall formulation stability.
Solution Approach 2:
The patent optimizes the concentration parameter of allergen within specific ranges that balance immunotherapy effectiveness with formulation stability. By carefully controlling allergen loading levels and adjusting related formulation parameters simultaneously, the patent achieves both high treatment efficacy and consumer-acceptable product stability.
3Ease of operation
If allergen delivery is integrated into daily toothbrushing routines to enhance compliance, then treatment adherence improves, but formulation requirements become more stringent
Solution Approach 1:
The patent makes the toothpaste formulation multi-functional by combining allergen delivery capabilities with standard toothpaste functions (cleaning, flavor, texture). This universal formulation allows the product to serve both as a therapeutic agent and a consumer-friendly oral care product, enhancing compliance without requiring separate treatment devices or complex administration procedures.
Solution Approach 2:
The patent enables self-service by incorporating allergen delivery directly into the routine toothbrushing activity. The formulation is designed to release allergens during normal brushing without requiring additional steps, devices, or professional administration. This self-service approach simplifies the treatment regimen and improves compliance while managing formulation complexity through integrated design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation maintains allergen stability and consumer acceptance, enhancing compliance by integrating allergen delivery into daily toothbrushing routines, thereby improving the efficacy of oral mucosal immunotherapy.
Implementation Method 1
increased viscosity modifiers, such as sugar alcohols and silica-based thickeners
Implementation Method 2
sugar alcohols and silica-based thickeners
Implementation Method 3
ensuring homogeneous mixing
Implementation Method 4
ensuring homogeneous mixing
Data Source
AI summary
Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes, and kits of the invention are also disclosed.